Shafran, S D <br/><br/>
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.  [electronic resource] 

 -  The New England journal of medicine  Aug 1996 
 - 377-83 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-4793 
<br/><br/><label>Standard No.: </label>10.1056/NEJM199608083350602  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS-Related Opportunistic Infections--drug therapy<br/>Adult<br/>Anti-Bacterial Agents--adverse effects<br/>Antitubercular Agents--therapeutic use<br/>Bacteremia--drug therapy<br/>Ciprofloxacin--therapeutic use<br/>Clarithromycin--therapeutic use<br/>Clofazimine--therapeutic use<br/>Drug Therapy, Combination<br/>Ethambutol--therapeutic use<br/>Female<br/>Humans<br/>Male<br/>Mycobacterium avium Complex--isolation & purification<br/>Mycobacterium avium-intracellulare Infection--drug therapy<br/>Rifabutin--adverse effects<br/>Rifampin--therapeutic use<br/>Survival Analysis<br/>Treatment Outcome<br/>Uveitis--chemically induced